Skip to content
  • Tuesday, 29 September 2026
  • 10:50 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • AI Can Accelerate Study-Build Foundations, But Only When Teams Combine Targeted Automation with Standards, Traceability and Control.
Pharmaceutical R&D

AI Can Accelerate Study-Build Foundations, But Only When Teams Combine Targeted Automation with Standards, Traceability and Control.

Teuku Ryan Jul 21, 2026 0

Artificial intelligence (AI) is rapidly transforming various sectors, and clinical data management is no exception. While the potential applications of…

Read More
Pharmaceutical R&D

Brinsupri Poised to Redefine Bronchiectasis Treatment Standards Following Robust ATS 2026 Showcase

Teuku Ryan Jun 2, 2026 0

The landscape of non-cystic fibrosis bronchiectasis (NCFB) treatment is undergoing a significant transformation with the emergence of Brinsupri (brensocatib), a…

Read More
Biotech & Genetic Research

Cavidi AB’s BOLD Technology Sets New Standards in Immunoassay Sensitivity and Precision for Biomedical Research and Diagnostics

Jia Lissa May 9, 2026 0

Cavidi AB is making significant strides in enhancing the capabilities of immunoassays, a cornerstone technique in diagnostics and biomedical research,…

Read More
Quintessence Biotech Unveils Groundbreaking Artificial Cell Technology to Revolutionize Cell and Gene Therapy ManufacturingRethinking the Laws of Chaos Researchers Discover Method to Manipulate Turbulent Energy Flux via Tensor GeometryKerendia Recommended for Broader Heart Failure Treatment in England, Offering New Hope for Patients with Preserved Ejection FractionScience News: A Century of Empowering Public Understanding of Science
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research StudyMolten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low TemperaturesDaiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA DiscussionsScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Dwi Wanna Sep 29, 2026
Advanced Materials Science
Molten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low Temperatures
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ